Stephanie L. Coffing

765 citations

26 papers · 649 indexed · h-index 14

Molecular Biology
Cancer Research top 10%
Health, Toxicology and Mutagenesis top 5%
Oncology
Pharmacology top 5%

Co-authors: William M. Baird David J. Riese Robert J. Mauthe Albrecht Seidel Andreas Luch Krista L. Dobo Maik Schuler Anneliese Schneider
Topics: Carcinogens and Genotoxicity Assessment (17 papers)DNA and Nucleic Acid Chemistry (6 papers)Effects and risks of endocrine disrupting chemicals (5 papers)
Cited by: Cancer Research Pharmacology Health, Toxicology and Mutagenesis
Journals: Oncogene Journal of Medicinal Chemistry Carcinogenesis
Partner nations: United States Germany

In The Last Decade

Stephanie L. Coffing

26 papers receiving 635 citations

Peers

Countries citing papers authored by Stephanie L. Coffing

Since Specialization

Citations

This map shows the geographic impact of Stephanie L. Coffing's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stephanie L. Coffing with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stephanie L. Coffing more than expected).

Fields of papers citing papers by Stephanie L. Coffing

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stephanie L. Coffing. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stephanie L. Coffing. The network helps show where Stephanie L. Coffing may publish in the future.

Co-authorship network of co-authors of Stephanie L. Coffing

This figure shows the co-authorship network connecting the top 25 collaborators of Stephanie L. Coffing. A scholar is included among the top collaborators of Stephanie L. Coffing based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stephanie L. Coffing. Stephanie L. Coffing is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Assessing the genotoxicity of N‐nitrosodiethylamine with three in vivo endpoints in male Big Blue® transgenic and wild‐type C57BL/6N mice 2024 ·Environmental and Molecular Mutagenesis ·(unknown),Stephanie L. Coffing,(unknown),(unknown),Richard A. Spellman,(unknown),Maik Schuler	9
2	2‐Hydroxypyridine N‐Oxide is not genotoxic in vivo 2019 ·Environmental and Molecular Mutagenesis ·Krista L. Dobo,Stephanie L. Coffing,(unknown),(unknown)	3
3	Fluorescent tubulin polymerization assay to characterize moa of genotoxic compounds — A validation study 2017 ·Journal of Pharmacological and Toxicological Methods ·Pamela L. Heard,(unknown),Stephanie L. Coffing,Krista L. Dobo,Maik Schuler	1
4	Compensatory erythropoiesis has no impact on the outcome of the in vivo Pig-a mutation assay in rats following treatment with the haemolytic agent 2-butoxyethanol 2015 ·Mutagenesis ·Michelle Kenyon,Stephanie L. Coffing,(unknown),(unknown),Stephen D. Dertinger,Kay A. Criswell,Krista L. Dobo	10
5	Development and validation of an in vitro micronucleus assay platform in TK6 cells 2012 ·Mutation Research/Genetic Toxicology and Environmental Mutagenesis ·Zhanna Sobol,(unknown),(unknown),Richard A. Spellman,Dingzhou Li,Andrew D. Scott,(unknown),Stephanie L. Coffing,Jennifer B. Munzner,(unknown),(unknown),Krista L. Dobo,Maik Schuler	28
6	Defining EMS and ENU dose–response relationships using the Pig-a mutation assay in rats 2011 ·Mutation Research/Genetic Toxicology and Environmental Mutagenesis ·Krista L. Dobo,(unknown),(unknown),(unknown),Zoryana Cammerer,Stephanie L. Coffing,(unknown),Maik Schuler	42
7	Report on stage III Pig‐a mutation assays using N‐ethyl‐N‐nitrosourea – comparison with other in vivo genotoxicity endpoints 2011 ·Environmental and Molecular Mutagenesis ·Zoryana Cammerer,Javed A. Bhalli,Xuefei Cao,Stephanie L. Coffing,(unknown),Krista L. Dobo,Vasily N. Dobrovolsky,Maria Engel,(unknown),(unknown),Robert H. Heflich,Mason G. Pearce,Joseph G. Shaddock,(unknown),(unknown),Maik Schuler	35
8	The rat gut micronucleus assay: A good choice for alternative in vivo genetic toxicology testing strategies 2010 ·Environmental and Molecular Mutagenesis ·Stephanie L. Coffing,Maria Engel,(unknown),(unknown),Richard A. Spellman,(unknown),Maik Schuler	13
9	Genotoxicity of 2-(3-Chlorobenzyloxy)-6-(piperazinyl)pyrazine, a Novel 5-Hydroxytryptamine2c Receptor Agonist for the Treatment of Obesity: Role of Metabolic Activation 2007 ·Drug Metabolism and Disposition ·Amit S. Kalgutkar,Deepak Dalvie,Jiri Aubrecht,Evan B. Smith,Stephanie L. Coffing,(unknown),(unknown),Mary E. Lame,(unknown),Kim F. McClure,Tristan S. Maurer,(unknown),(unknown),Klaas Schildknegt	36
10	Anilinodialkoxyquinazolines: Screening Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors for Potential Tumor Imaging Probes 2005 ·Journal of Medicinal Chemistry ·Henry F. VanBrocklin,John K. C. Lim,Stephanie L. Coffing,(unknown),(unknown),(unknown),Jennifer L. Gilmore,(unknown),David J. Riese	30
11	Five carboxyl-terminal residues of neuregulin2 are critical for stimulation of signaling by the ErbB4 receptor tyrosine kinase 2003 ·Oncogene ·Stuart Hobbs,Elizabeth Cameron,Robert P. Hammer,(unknown),Richard L. Gallo,(unknown),Stephanie L. Coffing,Han Chang,David J. Riese	23
12	Neuregulin isoforms exhibit distinct patterns of ErbB family receptor activation 2002 ·Oncogene ·Stuart Hobbs,Stephanie L. Coffing,(unknown),Elizabeth Cameron,Eric E. Williams,(unknown),(unknown),Robert P. Hammer,Chang Han,David J. Riese	70
13	Stable Expression of Human Cytochrome P450 1B1 in V79 Chinese Hamster Cells and Metabolically Catalyzed DNA Adduct Formation of Dibenzo[a,l]pyrene 1998 ·Chemical Research in Toxicology ·Andreas Luch,Stephanie L. Coffing,Yong Tang,Anneliese Schneider,(unknown),Helmut Greim,Colin R. Jefcoate,Albrecht Seidel,William F. Greenlee,William M. Baird,Johannes Doehmer	109
14	Stereoselective Activation of Dibenzo[a,l]pyrene and Its trans-11,12-Dihydrodiol to Fjord Region 11,12-Diol 13,14-Epoxides in a Human Mammary Carcinoma MCF-7 Cell-Mediated V79 Cell Mutation Assay 1997 ·Chemical Research in Toxicology ·Sherry L. Ralston,Stephanie L. Coffing,Albrecht Seidel,Andreas Luch,(unknown),William M. Baird	43
15	Metabolic activation of benzo[g]chrysene in the human mammary carcinoma cell line MCF-7. 1997 ·PubMed ·Rachana Agarwal,Stephanie L. Coffing,William M. Baird,Alexander S. Kiselyov,Ronald G. Harvey,Anthony Dipple	21
16	Exposure of mammalian cell cultures to benzo[a] and light results in oxidative DNA damage as measured by 8-hydroxydeoxyguanosine formation 1995 ·Carcinogenesis ·Robert J. Mauthe,(unknown),Stephanie L. Coffing,William M. Baird	68
17	Inhibition of benzo[a]pyrene metabolism by insulin, FITC-insulin and an FITC-insulin-antibody conjugate in the human hepatoma cell line HepG2 1995 ·Chemico-Biological Interactions ·R J Polzer,Stephanie L. Coffing,Craig B. Marcus,Sang S. Park,Harry V. Gelboin,William M. Baird	6
18	Stereoselectivity of Activation of 7,12-Dimethylbenz[a]anthracene 3,4-Dihydrodiol to the anti-Diol Epoxide Metabolite in a Human Mammary Carcinoma MCF-7 Cell-Mediated V79 Cell Mutation Assay 1995 ·Chemical Research in Toxicology ·(unknown),Stephanie L. Coffing,Hongmee Lee,Ronald G. Harvey,William M. Baird	10
19	The time-dependent increase in the binding of benzo[a]pyrene to DNA through (+)-anti-benzo[a]pyrene-7,8-diol-9,10-epoxide in primary rat hepatocyte cultures results from induction of cytochrome P450IA1 by benzo[a]pyrene treatment 1992 ·Carcinogenesis ·(unknown),Stephanie L. Coffing,John N. Anderson,Craig B. Marcus,Theodore J. Kalogeris,William M. Baird,(unknown),Harry V. Gelboin	18
20	Effects of biochanin A on metabolism, DNA binding and mutagenicity of benzo [a]pyrene in mammalian cell cultures 1991 ·Carcinogenesis ·Young-Heum Chae,Stephanie L. Coffing,(unknown),David K. Ho,John M. Cassady,William M. Baird	9

About Stephanie L. Coffing

Stephanie L. Coffing is a scholar working on Cancer Research, Health, Toxicology and Mutagenesis and Pharmacology, having authored 26 papers that have together received 649 indexed citations. Recurring topics across this work include Carcinogens and Genotoxicity Assessment (17 papers), DNA and Nucleic Acid Chemistry (6 papers) and Effects and risks of endocrine disrupting chemicals (5 papers). The work is most often cited by research in Cancer Research (293 citations), Pharmacology (99 citations) and Health, Toxicology and Mutagenesis (153 citations). Stephanie L. Coffing has collaborated with scholars based in United States and Germany. Frequent co-authors include William M. Baird, David J. Riese, Robert J. Mauthe, Albrecht Seidel, Andreas Luch, Krista L. Dobo, Maik Schuler, Anneliese Schneider, Colin R. Jefcoate and Stuart Hobbs. Their work appears in journals such as Oncogene, Journal of Medicinal Chemistry and Carcinogenesis.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact